Back to Authors

Sabnis, Anika R.

https://orcid.org/0009-0008-9940-6583

A5046238534 | I1330342723

Mayo Clinic

Citations 16

Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5-HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders

ACS Medicinal Chemistry Letters | April 28, 2026 | Volume: 17 | Issue: 5 | Pages: 1033-1034

10.1021/acsmedchemlett.6c00208 | PMID 42157830

Novel Compounds for Treating Huntington’s Disease

ACS Medicinal Chemistry Letters | March 4, 2026 | Volume: 17 | Issue: 4 | Pages: 792-793

10.1021/acsmedchemlett.6c00110 | PMID 41982720

Novel Substituted Pyrazolo-Pyrimidine Compounds as PIKfyve Inhibitors for Treating Neurological Diseases

ACS Medicinal Chemistry Letters | January 13, 2026 | Volume: 17 | Issue: 2 | Pages: 317-318

10.1021/acsmedchemlett.6c00012 | PMID 41704386

Novel Acrylamide Derivatives as Mitochondrial Permeability Transition Pore (mPTP) Inhibitors for Treating Neurodegenerative Diseases

ACS Medicinal Chemistry Letters | January 6, 2026 | Volume: 17 | Issue: 2 | Pages: 298-299

10.1021/acsmedchemlett.5c00778 | PMID 41704349

Novel Compounds as TREM2 Agonists for Treating Alzheimer’s Disease

ACS Medicinal Chemistry Letters | December 27, 2025 | Volume: 17 | Issue: 1 | Pages: 97-98

10.1021/acsmedchemlett.5c00751 | PMID 41531973

Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders

ACS Medicinal Chemistry Letters | December 16, 2025 | Volume: 17 | Issue: 1 | Pages: 79-80

10.1021/acsmedchemlett.5c00731 | PMID 41531978